Ctxr sec filings
WebFind the latest SEC Filings data for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Citius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings … WebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search …
Ctxr sec filings
Did you know?
WebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … WebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials …
WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … WebMay 13, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 13 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.
WebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News … WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing.
WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. maple leaf foods supply chainWebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio. kreationsphasenmodell nach tiedtWebApr 6, 2024 · Citius Pharmaceuticals, Inc. SEC Filing - Quarterly Report (10-Q) February 10, 2024 SEC FilingsFri, Feb. 10 Citius Pharmaceuticals, Inc. SEC Filing - Proxy … maple leaf foods poultryWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. maple leaf foods press releaseWebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... maple leaf foods recallWebThis table shows the interest rate that must be paid by a short seller of US:CTXR to the lender of that security. This fee is shown as an annual percentage rate (APR). Lenders are funds or individuals that own the … maple leaf foods stockhouseWebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. maple leaf foods processing plant